Related Experiment Video

Updated: Jul 3, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Late adverse events after drug-eluting stent implantation

David F Kong1, Eric L Eisenstein, Robert Harrington

  • 1Duke Clinical Research Institute, DUMC Box 3850, Durham, NC 27710, USA. David.F.Kong@duke.edu

Current Cardiology Reports
|July 10, 2008
PubMed

Insights

Drug-eluting stents (DES) initially reduced repeat procedures for coronary artery revascularization. However, long-term data revealed risks of late stent thrombosis, prompting further investigation into DES safety and efficacy.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomaterials Science

Background:

  • Drug-eluting stents (DES) are crucial for preventing restenosis after percutaneous coronary artery revascularization.
  • Initial randomized trials in low-risk patients supported the regulatory approval of DES.
  • Concerns regarding late stent thrombosis emerged from long-term outcome meta-analyses in 2006.

Purpose of the Study:

  • To critically appraise the late adverse effects associated with drug-eluting stents.
  • To evaluate the strengths and limitations of various evidence sources, including registries, clinical trials, and meta-analyses.
  • To highlight the collaborative efforts in generating robust evidence for DES safety.

Main Methods:

  • Appraisal of long-term outcomes from randomized trials and meta-analyses.
  • Analysis of data from large national registries.
  • Review of evidence from focused, well-conducted clinical trials.

Main Results:

  • Drug-eluting stents (DES) demonstrated efficacy in preventing restenosis but raised concerns about late stent thrombosis (>9 months post-procedure).
  • Large national registries, clinical trials, and meta-analyses provide critical insights into DES performance.
  • Evidence synthesis reflects a convergence of academic, industry, and public health interests.

Conclusions:

  • Long-term safety surveillance is essential for understanding the full impact of medical devices like DES.
  • The interplay between different study designs (registries vs. trials) is crucial for comprehensive evidence generation.
  • Robust evidence bases are vital for informed clinical decision-making and public health policy regarding cardiovascular interventions.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...